-

Longhorn Vaccines and Diagnostics to Present at The Allen D. Leman Swine Conference

BETHESDA & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics LLC, a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced that Jerry Torrison, DVM, PhD, Senior Vice President of Animal Health, will present at the Allen D. Leman Swine Conference, being held in the St. Paul River Center, Minnesota, on Sept. 17 – 20, 2022.

Dr. Torrison will be giving the Morrison Lectureship, named in honor of Dr. Bob Morrison, his PhD advisor, for his work in the areas of swine disease epidemiology and factors that drive economics and productivity in the swine industry.

Presentation Title: FADs,..Are We Ready (Together)?
Presenter: Jerry Torrison, DVM, PhD, Senior Vice President of Animal Health at Longhorn Vaccines and Diagnostics
Abstract Title: Foreign Animal Disease (FAD) Response
Session Date: Sept. 20, 2022
Session Time: 9:00 – 10:00am CST
Session Location: The St. Paul River Centre, Minnesota

About Longhorn Vaccines and Diagnostics LLC

Longhorn Vaccines and Diagnostics LLC is a One Health company based in Maryland that is developing vaccines and diagnostic tools for worldwide public health concerns and to prevent future pandemics. Since its inception in 2006, Longhorn has focused on developing vaccines and diagnostic tools that can impact a pandemic on a global scale and at all socio-economic levels. Since pandemics flow between humans and animals, Longhorn caters to both in order to surveil, diagnose, prevent and treat the next infectious disease.

Longhorn’s core product, PrimeStore® Molecular Transport Medium (MTM), is a patented, FDA cleared, state-of-the-art ambient temperature molecular diagnostic collection and transport device that can help governments, global health organizations, and drug manufacturers improve the diagnosis and treatment of highly infectious diseases such as Influenza, SARS-CoV-2, and Mycobacterium tuberculosis (TB). Unlike standard devices for collecting and transporting virus samples, PrimeStore® MTM is the first molecular transport device that can safely deactivate pathogens and stabilize RNA and DNA, allowing enhanced point of care and ambient temperature transport for laboratory based molecular testing and characterization.

Contacts

Longhorn Vaccines and Diagnostics LLC
Jeffrey Fischer
Email: jeff@lhnvd.com

Media
Alexis Feinberg – ICR Westwicke PR
Email:  LonghornPR@icrinc.com

Longhorn Vaccines and Diagnostics LLC


Release Versions

Contacts

Longhorn Vaccines and Diagnostics LLC
Jeffrey Fischer
Email: jeff@lhnvd.com

Media
Alexis Feinberg – ICR Westwicke PR
Email:  LonghornPR@icrinc.com

More News From Longhorn Vaccines and Diagnostics LLC

Longhorn Vaccines and Diagnostics to Present Data on Single and Dual Peptide Universal Influenza Candidates at ESCMID 2025

BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing treatments and diagnostic tools for global public health and zoonosis concerns, will present new data from universal influenza pipeline candidates during two poster sessions at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2025. Longhorn will also be available at booth C108 in Hall B to discuss its differentiated approach to the...

Longhorn Vaccines and Diagnostics Honors World TB Day 2025, Underscoring a Commitment to Eradicating Tuberculosis with PrimeStore® MTM

BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today honors World Tuberculosis (TB) Day 2025 by reaffirming its commitment to ending TB globally through PrimeStore® MTM, the only FDA-cleared sample collection and transport device. PrimeStore enables safer, more accurate, and cost-effective TB sample collection and transport, thereby expanding acce...

Longhorn Vaccines and Diagnostics Composite Peptide Vaccine Combats Sepsis Related to Antimicrobial Resistant Tuberculosis

BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, presented new data at the Union World Conference on Lung Health on LHNVD-303, the company's composite peptide vaccine for sepsis. LHNVD-303 is designed to prevent bacterial infections, and clear associated toxins, including those related to Mycobacterium tuberculosis, using a targeted combination of l...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.